Evaluation of methicillin-resistant Staphylococcus aureus nasal carriage in Malagasy patients

J Infect Dev Ctries. 2013 Apr 17;7(4):318-22. doi: 10.3855/jidc.2460.

Abstract

Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of infections. It is well recognized that nasal carriage of S. aureus represents a potent and increasingly prevalent risk factor for subsequent S. aureus infection. However, in Madagascar no data exist concerning this nasal carriage of S. aureus.

Methodology: Nasal swabs from 304 different patients attending the Laboratory of Training and Research in Medical Biology of Madagascar were cultured for methicillin sensitive (MSSA) and MRSA.

Results: One hundred and sixteen patients had S. aureus in their noses (38.16 ± 5.46%) of whom 45 (14.80 ± 3.99%) had MRSA. A risk factor for MSSA nasal carriage included a history of hospitalization when antibiotics were administered (odds ratio [OR] 2.25, 1.09 - 4.64). Among MRSA nasal isolates, high rate of resistance to other antibiotics was observed, particularly for trimethoprim-sulfamethoxazole (68.89%), erythromycin (66.67%) and ofloxacin (53.33%).

Conclusions: Our data showed a high rate of MRSA nasal carriage and a high rate of multidrug resistance. A strategic policy against the spread of multidrug resistant strains is desirable.

MeSH terms

  • Adolescent
  • Adult
  • Carrier State / microbiology*
  • Confidence Intervals
  • Drug Resistance, Multiple, Bacterial
  • Erythromycin / pharmacology
  • Female
  • Hospitalization
  • Humans
  • Madagascar / epidemiology
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Microbial Sensitivity Tests
  • Middle Aged
  • Nose / microbiology*
  • Ofloxacin / pharmacology
  • Prevalence
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Surveys and Questionnaires
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology
  • Young Adult

Substances

  • Erythromycin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Ofloxacin